Nexalin Technology (NXL) Revenue (2021 - 2026)
Nexalin Technology's (NXL) quarterly Revenue came in at $14950.0 in Q1 2026, down 63.55% year-on-year from $41015.0 in Q1 2025, and down 91.3% quarter-over-quarter from $171895.0 in Q4 2025.
Nexalin Technology (NXL) Revenue (2021 - 2026) Analysis & Trends
Nexalin Technology's Revenue history runs 6 years deep, the most recent figure standing at $14950.0 for Q1 2026.
- On a quarterly basis, Revenue fell 63.55% year-over-year to $14950.0 in Q1 2026; TTM through Mar 2026 was $275582.0, a 110.26% increase from a year earlier, with the FY2025 full-year figure at $301647.0, up 78.78% from the prior year.
- Revenue retreated to $14950.0 in Q1 2026 per NXL's latest filing, from $171895.0 in the prior quarter.
- Across five years, Revenue topped out at $545323.0 in Q3 2022 and bottomed at $14950.0 in Q1 2026.
- The 5-year median for Revenue is $36031.0 (2024), against an average of $112789.6.
- Across the five-year window, Revenue jumped 874.31% in 2022 and slumped 95.58% in 2023, its largest moves.
- Year by year, Revenue stood at $38424.0 in 2022, then sank by 46.55% to $20536.0 in 2023, then jumped by 32.35% to $27179.0 in 2024, then jumped by 532.46% to $171895.0 in 2025, then sank by 91.3% to $14950.0 in 2026.
- Per Business Quant, the three latest NXL Revenue figures stand at $14950.0 (Q1 2026), $171895.0 (Q4 2025), and $18149.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 11.16 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.02 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 9.81 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 5.20 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.65 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.19 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.57 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nexalin Technology | 9.32 Mn | 6.61 Mn | 13,133.00 | 14,950.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14,950.00 |
| Dec 31, 2025 | 171,895.00 |
| Sep 30, 2025 | 18,149.00 |
| Jun 30, 2025 | 70,588.00 |
| Mar 31, 2025 | 41,015.00 |
| Dec 31, 2024 | 27,179.00 |
| Sep 30, 2024 | 36,031.00 |
| Jun 30, 2024 | 26,840.00 |
| Mar 31, 2024 | 78,671.00 |
| Dec 31, 2023 | 20,536.00 |
| Sep 30, 2023 | 24,113.00 |
| Jun 30, 2023 | 35,540.00 |
| Mar 31, 2023 | 30,560.00 |
| Dec 31, 2022 | 38,424.00 |
| Sep 30, 2022 | 545,323.00 |
| Jun 30, 2022 | 414,288.00 |
| Mar 31, 2022 | 323,322.00 |
| Dec 31, 2021 | 23,999.00 |
| Sep 30, 2021 | 55,970.00 |